Adaptive Biotechnologies earnings were -$141.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ADPT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$29.9M, down 11.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADPT reported annual earnings of -$159.5M, with -29.2% growth.
Adaptive Biotechnologies Earnings Reports & History FAQ
What were Adaptive Biotechnologies's earnings last quarter?
On ADPT's earnings call on Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 2025 earnings per share (EPS) of -$0.20, up 39.39% year over year. Total ADPT earnings for the quarter were -$29.85 million. In the same quarter last year, Adaptive Biotechnologies's earnings per share (EPS) was -$0.33.
Is Adaptive Biotechnologies profitable or losing money?
As of the last Adaptive Biotechnologies earnings report, Adaptive Biotechnologies is currently losing money. Adaptive Biotechnologies's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$141.84 million, a 34.05% decrease year over year.
What was ADPT's earnings growth in the past year?
As of Adaptive Biotechnologies's earnings date in Invalid Date, Adaptive Biotechnologies's earnings has grown year over year. ADPT earnings in the past year totalled -$141.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.